A drug called tesamorelin helps HIV patients with belly fat buildup lose about 11% of their dangerous internal belly fat in six months, while those on a dummy pill lose almost none.

Scientific Claim

Tesamorelin reduces visceral adipose tissue by 10.9% (21 cm²) in HIV-infected patients on antiretroviral therapy with abdominal fat accumulation after 6 months of treatment compared to placebo (P < 0.0001).

Original Statement

“VAT decreased by −10.9% (−21 cm2) in the tesamorelin group vs. −0.6% (−1 cm2) in the placebo group in the 6-month efficacy phase, P < 0.0001.”

From study:Effects of Tesamorelin, a Growth Hormone–Releasing Factor, in HIV-Infected Patients With Abdominal Fat Accumulation: A Randomized Placebo-Controlled Trial With a Safety Extension

Evidence Quality Assessment

Claim Status

appropriately stated

Study Design Support

Design supports claim

Appropriate Language Strength

definitive

Can make definitive causal claims

Assessment Explanation

The study is a randomized controlled trial with a control group, which allows for causal inference. The verb 'reduces' is appropriate for this design.

Evidence from Studies

Supporting (1)

Effects of Tesamorelin, a Growth Hormone–Releasing Factor, in HIV-Infected Patients With Abdominal Fat Accumulation: A Randomized Placebo-Controlled Trial With a Safety Extension

Randomized Controlled Trial

Human

2010 Mar

In a well-done study, HIV patients with belly fat who took tesamorelin lost about 11% of their dangerous belly fat in 6 months, while those on a dummy pill lost almost nothing — proving the drug works.

Contradicting (0)

No contradicting evidence found

Source Study

Effects of Tesamorelin, a Growth Hormone–Releasing Factor, in HIV-Infected Patients With Abdominal Fat Accumulation: A Randomized Placebo-Controlled Trial With a Safety Extension

Score: 81

DOI: 10.1097/QAI.0b013e3181cbdaff

Similar Assertions

A drug called tesamorelin helps reduce belly fat deep inside the abdomen for people with HIV who are on medication, making their belly fat decrease by about 15% compared to those not taking the drug. This finding is from the abstract summary - full study details were not available

99%

A hormone treatment called tesamorelin decreases belly fat by 42 square centimeters more than a placebo in people with HIV who have excess abdominal fat after six months of treatment.

97%

A daily injection called tesamorelin helps HIV patients on medication lose belly fat inside their abdomen, while a fake shot doesn’t.

97%

Continuing tesamorelin for a full year helps HIV patients with belly fat lose nearly 18% of their dangerous internal belly fat, with no loss of benefit over time.

96%

The drug only melts the fat deep inside the belly, not the fat you can pinch on the skin or in the arms and legs.

95%